Open AccessHuman beta-endorphin: specific binding in neuroblastoma N18TG2 cells.
Author(s) -
R. Glenn Hammonds,
C H Li
Publication year - 1981
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.78.11.6764
Subject(s) - beta (programming language) , binding site , beta endorphin , neuroblastoma , chemistry , cell culture , enzyme , biochemistry , microbiology and biotechnology , biology , genetics , computer science , programming language
The mouse neuroblastoma N18TG2 has specific, saturable binding sites for human beta-endorphin (beta h-EP). The affinity and number of sites are 1.1 nM and 280,000 per cell, respectively, beta h-EP binding is not inhibited by [Leu]enkephalin or morphine at concentrations up to 0.1 mM; beta h-EP-(6--31) is a potent inhibitor of binding, and camel beta-EP is much less potent. The data suggest the importance of the nonenkephalin segment of the beta h-EP molecule for interaction with the binding site in N18TG2 cells.